Lundbeck Extends Medidata EDC Contract

H. Lundbeck A/S has extended its agreement to use the Medidata Solutions’ Rave electronic data capture (EDC) and clinical data management (CDM) platform for a multi-year period, building on the success of the relationship in the initial three-year contract.

Lundbeck focuses on therapies for CNS disorders, including depression and anxiety, schizophrenia, insomnia, Huntington’s, Alzheimer’s and Parkinson’s diseases. Headquartered in Copenhagen with 5,900 employees around the world, Lundbeck selected Rave in 2007 as an enterprise-wide EDC system based on its ability to handle large, complex, global studies and its collaboration-enabling data collection, management and reporting capabilities. Since then, Lundbeck has used Medidata Rave in all Phase II-III clinical studies, covering a broad range of patients, countries and sites. The new multi-year contract calls for Rave use in all of Lundbeck’s upcoming Phases II and III trials.